Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disordersJacqueline Palace, Sean J. Pittock, Maria Isabel Leite et al.|Brain|2019Cited by 205
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patientsDaniel Whittam, Brigitte Wildemann, Álvaro Cobo‐Calvo et al.|Multiple Sclerosis and Related Disorders|2020Cited by 179
Area postrema syndromeEslam Shosha, Sean J. Pittock, Divyanshu Dubey et al.|Neurology|2018Cited by 175
Treatment of MOG antibody associated disorders: results of an international survey.Daniel Whittam, Eric C. Klawiter, A. Jacob et al.|Research Padua Archive (University of Padua)|2020Cited by 139
Rituximab in neurological disease: principles, evidence and practiceDaniel Whittam, Anu Jacob|Practical Neurology|2018Cited by 96